Professor, Pediatrics, Virginia Commonwealth U SOM
Pediatric Pulmonology
Dr. Michael S. Schechter, MD
|
|
Give Review
Michael Schechter works in the field of Pediatric Pulmonology. He researched medicine at University at Buffalo, School of Medicine and Biomedical Sciences. He has 1 awards "Fellow (FAAP)". Doctor Michael S. Schechter, MD is a published doctor and has 55 publications published. The lastest was: 'Methodologic standards for the evaluation of diagnostic tests: the need to evaluate the standards.'
Publications
- Sociodemographic Attributes and Spina Bifida Outcomes.
- Antibiotic treatment of signs and symptoms of pulmonary exacerbations: A comparison by care site.
- Pulmonary function outcomes for assessing cystic fibrosis care.
- Risk factors for quantity not sufficient sweat collection in infants 3 months or younger.
- Key findings of the US Cystic Fibrosis Foundation's clinical practice benchmarking project.
- Antiviral efficacy of entecavir in nucleos(t)ide-naïve patients of Black/African descent with chronic hepatitis B.
- Pulmonary exacerbations in cystic fibrosis: young children with characteristic signs and symptoms.
- Long-term effects of pregnancy and motherhood on disease outcomes of women with cystic fibrosis.
- Wealth as a disease modifier in cystic fibrosis.
- Testing the feasibility of a National Spina Bifida Patient Registry.
- Benchmarking to improve the quality of cystic fibrosis care.
- Comparison of the US and Australian Cystic Fibrosis Registries: The Impact of Newborn Screening.
- Chronic Kidney Disease: A New Morbidity of Cystic Fibrosis or an Old Morbidity of Diabetes Mellitus?
- Nongenetic influences on cystic fibrosis outcomes.
- Results of a phase IIa study of VX-809, an investigational CFTR corrector compound, in subjects with cystic fibrosis homozygous for the F508del-CFTR mutation.
- Location and duration of treatment of cystic fibrosis respiratory exacerbations.
- Age of Pseudomonas aeruginosa acquisition and subsequent severity of cystic fibrosis lung disease.
- Origins of outcome disparities in pediatric respiratory disease.
- Improving the quality of care for patients with cystic fibrosis.
- Airway clearance in cystic fibrosis: is there a better way?
- Impact of socioeconomic status, race, and ethnicity on quality of life in patients with cystic fibrosis in the United States.
- Healthcare expenditures for privately insured people with cystic fibrosis.
- Anxiety and depression in cystic fibrosis.
- Evaluating the evidence for airway-clearance therapy in cystic fibrosis.
- Substrate utilization during and after exercise in mild cystic fibrosis.
- Models of comprehensive multidisciplinary care for individuals in the United States with genetic disorders.
- Patient registry analyses: seize the data, but caveat lector.
- Airway clearance applications in infants and children.
- Follow-up study of a randomized controlled trial of postnatal dexamethasone therapy in very low birth weight infants: effects on pulmonary outcomes at age 8 to 11 years.
- Impact of pregnancy on women with cystic fibrosis.
- Improving subspecialty healthcare: lessons from cystic fibrosis.
- Sweat-testing in preterm and full-term infants less than 6 weeks of age.
- Effect of macrolides on in vivo ion transport across cystic fibrosis nasal epithelium.
- Outcomes associated with initiation of different controller therapies in a Medicaid asthmatic population: a retrospective data analysis.
- Non-genetic influences on CF lung disease: the role of sociodemographic characteristics, environmental exposures and healthcare interventions.
- Snoring: investigations guidelines.
- Non-genetic influences on cystic fibrosis lung disease: the role of sociodemographic characteristics, environmental exposures, and healthcare interventions.
- Acute renal failure in cystic fibrosis: association with inhaled tobramycin therapy.
- Lung function decline from adolescence to young adulthood in cystic fibrosis.
- Health inequalities and cystic fibrosis.
- Socioeconomic status and the likelihood of antibiotic treatment for signs and symptoms of pulmonary exacerbation in children with cystic fibrosis.
- Association of socioeconomic status with the use of chronic therapies and healthcare utilization in children with cystic fibrosis.
- Presence of methicillin resistant Staphylococcus aureus in respiratory cultures from cystic fibrosis patients is associated with lower lung function.
- Genetic and non-genetic determinants of outcomes in cystic fibrosis.
- Infant care patterns at epidemiologic study of cystic fibrosis sites that achieve superior childhood lung function.
- Nontuberculous mycobacteria. I: multicenter prevalence study in cystic fibrosis.
- Technical report: diagnosis and management of childhood obstructive Sleep apnea syndrome.
- The association of socioeconomic status with outcomes in cystic fibrosis patients in the United States.
- Relationship between socioeconomic status and disease severity in cystic fibrosis.
- Baseline characteristics and factors associated with nutritional and pulmonary status at enrollment in the cystic fibrosis EPIC observational cohort.
- Chest pain in a patient with cystic fibrosis.
- High-resolution inspiratory and expiratory CT in older children and adults with bronchopulmonary dysplasia.
- Dosage of aspirin and acetaminophen.
- Methodologic standards for the evaluation of diagnostic tests: the need to evaluate the standards.
Schools
U OF BUFFALO SUNY SCH OF MED amp BIOMEDICAL SCI
Conditions Treated
- Sleep Apnea
Doctors Specialties
- Pediatric Pulmonology
Accepted Insurances
Awards
- Fellow (FAAP)
Education
-
University of North Carolina Hospitals -
University at Buffalo, School of Medicine and Biomedical Sciences
Hospital
-
Emory University Hospital
Helpful Reviews
Similar Doctors
|
|
Dr. Viral D. Kothari, MD |
|
Dr. Alicia C. Della Volpe, MD |
|
|
Dr. Nico Vehse, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Anthony L. Mansell, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Karen Daigle, MD
This Doctor is OpenDoctor Recommended.
|